Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

An Infectious Disease Case Study

Read the Case Study

About the Case Study

To successfully manage an Acute Bacterial Skin and Skin Structure Infection (ABSSSI) study, Pharm-Olam provided a complete enrollment solution for the management and data submission of this multi-region study. With the increase of ABSSSI diagnoses and ABSSSI-related hospitalizations, inconsistent treatment methods for those diagnosed, and resistance to previous standards of care makes this an important study for those in need.

We delivered a total of 380 patients for this particular study within 9 months, which allowed for the study to be completed 2 months ahead of time.



 

How can we help you create a healthier world?

Talk to one of our experts today.

Please choose one.

Contact Us